Patents by Inventor Peter N. Morcos

Peter N. Morcos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dosing for treatment with anti-CD20/anti-CD3 bispecific antibody
    Patent number: 12729243
    Abstract: The present invention relates to methods of treating a B-cell proliferative disorder by administering an anti-CD20/anti-CD3 bispecific antibody, and methods for reduction of adverse effects in response to the administration of the anti-CD20/anti-CD3 bispecific antibody. The present invention further relates to combination treatment methods of treating a B-cell proliferative disorder.
    Type: Grant
    Filed: April 29, 2022
    Date of Patent: September 8, 2026
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Linda Lundberg, Peter N. Morcos, Martin Weisser, Axel Boehnke, David Carlile, Nassim Djebli